Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 4
2013 2
2014 3
2015 5
2016 7
2017 7
2018 4
2019 4
2020 2
2021 3
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group. Kappos L, et al. N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089952 Free article. Clinical Trial.
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
[Multimodality of clinical effects of orexin].
Yakupov EZ, Artemieva DV, Troshina YV. Yakupov EZ, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(12):114-119. doi: 10.17116/jnevro2018118121114. Zh Nevrol Psikhiatr Im S S Korsakova. 2018. PMID: 30698570 Russian.
['Point of no return' in diabetic neuropathies: a dangerous delusion].
Akhmadeeva LR, Akhmedzanova LT, Barinov AN, Burdakov VV, Guryanova EA, Kopishinskaya SV, Makhinov KA, Parkhomenko EV, Sergienko DA, Strokov IA, Cherkasova VG, Shcherbonosova TA, Yakupov EZ. Akhmadeeva LR, et al. Among authors: yakupov ez. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(8):98-107. doi: 10.17116/jnevro201911908198. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31626177 Russian.
45 results